P. Ortega

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Patterns of Physical Activity Progression in Patients With COPD.

R. Rodríguez-Roisín, M. Polkey, M. Puhan, 2020, Archivos de bronconeumologia.

Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial

R. Rodríguez-Roisín, M. Benet, J. Garcia-Aymerich, 2018, European Respiratory Journal.

Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP)

J. Signes-Costa, A. Moreno, C. Valenzuela, 2013 .

Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial

R. Rodríguez-Roisín, M. Benet, J. Garcia-Aymerich, 2017 .

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

G. Raghu, M. Scholand, J. Albayda, 2022, The Lancet. Respiratory medicine.

Benefits from a program for “early interstitial lung diseases” in primary care centers

P. Luburich, J. Dorca, R. Llatjós, 2017 .

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.